Sphingolipids in mammalian cell signalling

Cellular and Molecular Life Sciences

Volumn 58, Issue 14, 2001, Pages 2053-2068

  Ohanian, J ^a   Ohanian, V ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Caveolae; Ceramide; Lipid raft; Signal transduction; Sphingomyelin; Sphingosine 1 phosphate

Indexed keywords

CERAMIDE; G PROTEIN COUPLED RECEPTOR; GLYCOSPHINGOLIPID; GLYCOSYLINOSITOLPHOSPHATE ANCHORED PROTEIN; PROTEIN TYROSINE KINASE; SPHINGOLIPID; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG;

APOPTOSIS; BILAYER MEMBRANE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; ENDOSOME; HYDROLYSIS; IMMUNE RESPONSE; LYSOSOME; MORPHOGENESIS; PROTEIN DOMAIN; REVIEW; SECOND MESSENGER; SENESCENCE; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 0035660246     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000836     Document Type: Review

References (170)

1. Inositol trisphosphate and diacylglycerol: Two interacting second messengers
2. Signaling pathways between the plasma membrane and endoplasmic reticulum calcium stores
3. Protein kinase C and lipid signalling for sustained cellular responses
4. Phospholipase D: Eenzymology, mechanisms of regulation, and function
5. Mammalian diacylglycerol kinases, a family of lipid kinases with signaling functions
6. Arachidonic acid in cell signaling
7. Signalling through phosphoinositide 3-kinases: The lipids take centre stage
8. The PI3K-PDK1 connection: More than just a road to PKB
9. Sphingomyelin turnover induced by vitamin D3 in HL-60 cells: Role in cell differentiation
10. The sphingomyelin cycle and the second messenger function of ceramide
11. Physiology and pathophysiology of sphingolipid metabolism and signaling
12. Sphingolipids - The enigmatic lipid class. Biochemistry, physiology, and pathophysiology
13. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets
14. Functions of ceramide in coordinating cellular-responses to stress
15. Stress signals for apoptosis: Ceramide and c-Jun kinase
16. Physiology of apoptosis
17. Functional rafts in cell membranes
18. The role of lipid rafts in T cell antigen receptor (TCR) signalling
19. Cholesterol depletion delocalizes phosphatidylinositol bisphosphate and inhibits hormone-stimulated phosphatidylinositol turnover
20. Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae
21. Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor
22. Static and dynamic lipid assymmetry in cell membranes
23. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells
24. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages
25. Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine
26. Sphingomyelin hydrolysis to ceramide during the execution phase of apoptosis results from phospholipid scrambling and alters cell-surface morphology
27. An update of the enzymology and regulation of sphingomyelin metabolism
28. Reconstitution of membranes simulating 'glycosignaling domain' and their susceptibility to lyso-GM3
29. Sphingomyelin-cholesterol interactions in biological and model membranes
30. Lipid composition of the normal human brain: Gray matter, white matter, and myelin
31. Phases and phase transitions of the sphingolipids
32. Interaction of cholesterol with sphingomyelins and acyl-chain-matched phosphatidylcholines: A comparative study of the effect of the chain length
33. Intracellular transport and metabolism of sphingomyelin
34. Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation
35. Identification of a distinct pool of sphingomyelin involved in the sphingomyelin cycle
36. CD95 signaling via ceramide-rich membrane rafts
37. The formation of sphingomyelin from phosphatidylcholine in plasma membrane preparations from mouse fibroblasts
38. Intraluminal calcium modulates lipid dynamics of rat intestinal brush-border membranes
39. Conversion of diacylglycerol to phosphatidylcholine on the basolateral surface of epithelial (Madin-Darby canine kidney) cells: Evidence for the reverse action of a sphingomyelin synthase
40. Enzyme distributions in subcellular fractions of BHK cells infected with Semliki forest virus: Evidence for a major fraction of sphingomyelin synthase in the trans-golgi network
41. Nuclear membrane sphingomyelin-cholesterol changes in rat liver after hepatectomy
42. Changes in the balance between mitogenic and antimitogenic lipid second messengers during proliferation, cell arrest, and apoptosis in T-lymphocytes
43. Basic fibroblast growth factor-induced proliferation of primary astrocytes: Evidence for the involvement of sphingomyelin biosynthesis
44. The antiviral, antitumoural xanthate D609 is a competitive inhibitor of phosphatidylcholine-specific phospholipase C
45. Hydrolysis of phosphatidylcholine couples ras to activation of raf protein kinase during mitogenic signal transduction
46. Involvement of phosphatidylcholine-specific phospholipase C in platelet-derived growth factor-induced activation of the mitogen-activated protein kinase pathway in Rat-1 fibroblasts
47. Evidence for a bifurcation of the mitogenic signaling pathway activated by Ras and phosphatidylcholine-hydrolyzing phospholipase C
48. Hydrolysis of phosphatidylcholine is stimulated by Ras proteins during mitogenic signal transduction
49. The synthesis of sphingomyelin in the Morris hepatomas 7777 and 5123D is restricted to the plasma membrane
50. Differential effects of sphingomyelin hydrolysis and resynthesis on the activation of NF-kappa B in normal and SV40-transformed human fibroblasts
51. Diacylglycerols and phosphatidates: Which molecular species are intracellular messengers?
52. Regulation of ceramide production and apoptosis
53. Sphingomyelinases in cell regulation
54. The role of ceramide in cell signaling
55. Signalling sphingomyelinases: Which, where, how and why?
56. Isolation of cDNA clones encoding human acid sphingomyelinase: Occurrence of alternatively processed transcripts
57. Human acid sphingomyelinase: Isolation, nucleotide sequence and expression of the full-length and alternatively spliced cDNAs
58. Sphingomyelinases and Niemann-Pick disease
59. Two new mutations in the acid sphingomyelinase gene causing type a Niemann-pick disease: N389T and R441X
60. Cloned mammalian neutral sphingomyelinase: Functions in sphingolipid signaling?
61. Tumor necrosis factor-alpha activates the sphingomyelin signal transduction pathway in a cell-free system
62. Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1 beta
63. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis
64. The subcellular localization of neutral sphingomyelinase in rat liver
65. Localization of neutral magnesium-stimulated sphingomyelinase in plasma membrane of cultured neuroblastoma cells
66. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced 'acidic' sphingomyelin breakdown
67. Functional dichotomy of neutral and acidic sphingomyelinases in tumour necrosis factor signalling
68. Compartmentalized production of ceramide at the cell surface
69. Signal-transduction through lipid 2nd-messengers
70. Lipid second messengers derived from glycerolipids and sphingolipids, and their role in smooth muscle function
71. Signal transduction in cellular senescence
72. Cell-cycle-dependent changes in ceramide levels preceding retinoblastoma protein dephosphorylation in G2/M
73. Induction of apoptosis through B-cell receptor cross-linking occurs via de novo generated C16-ceramide and involves mitochondria
74. Ceramide in the eukaryotic stress response
75. A novel pathway for tumor necrosis factor-alpha and ceramide signaling involving sequential activation of tyrosine kinase, p21(ras), and phosphatidylinositol 3-kinase
76. Caveolin 1-mediated regulation of receptor tyrosine kinase-associated phosphatidylinositol 3-kinase activity by ceramide
77. Cross-talk between phosphatidylinositol 3-kinase and sphingomyelinase pathways as a mechanism for cell survival/death decisions
78. Novel signaling pathways contributing to vascular changes in hypertension
79. Effects of neutral sphingomyelinase on phenylephrine-induced vasoconstriction and Ca(2+) mobilization in rat aortic smooth muscle
80. Src kinase and PI 3-kinase as a transduction pathway in ceramide-induced contraction of colonic smooth muscle
81. Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes
82. Ceramide in apoptosis - Does it really matter?
83. Ceramide and apoptosis
84. Induction of apoptotic DNA fragmentation and cell death by natural ceramide
85. Ceramide stimulates a cytosolic protein phosphatase
86. Ceramide-activated protein phosphatase: Partial purification and relationship to protein phosphatase 2A
87. Phosphatidic acid is a potent and selective inhibitor of protein phosphatase 1 and an inhibitor of ceramide-mediated responses
88. C-jun is a downstream target for ceramide-activated protein phosphatase in a431 cells
89. Regulation of cell cycle progression and nuclear affinity of the retinoblastoma protein by protein phosphatases
90. Ceramide inactivates cellular protein kinase Calpha
91. Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A
92. Characterisation of a ceramide activated protein kinase: Stimulation by tumour necrosis factor α
93. Kinase suppressor of Ras is ceramide-activated protein kinase
94. Protein kinase ζ isoform is critical for κB-dependent promoter activation by sphingomyelinase
95. Cathepsin D targeted by acid sphingomyelinase-derived ceramide
96. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha
97. Ceramide as an activator lipid of cathepsin D
98. Exchange of C(16)-ceramide between phospholipid vesicles
99. Ceramide-induced translocation of protein kinase C ζ in primary cultures of astrocytes
100. Hypothesis: Ceramide conditionally activates atypical protein kinases C, Raf-1 and KSR through binding to their cysteine-rich domains
101. The mode of ceramide action: The alkyl chain protrusion model
102. Biophysics of ceramide signaling: Interaction with proteins and phase transition of membranes
103. Ceramide enables fas to cap and kill
104. Bcl-2 interrupts the ceramide-mediated pathway of cell-death
105. Cross-talk between the bioactive glycerolipids and sphingolipids in signal transduction
106. Inhibition of the anti-apoptotic PI(3)K/Akt/Bad pathway by stress
107. Inhibition of PKB/Akt1 by C2-ceramide involves activation of ceramide-activated protein phosphatase in PC12 cells
108. Ceramide dissociates 3′-phosphoinositide production from pleckstrin homology domain translocation
109. Ceramide impairs the insulin-dependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells
110. Differential activation of phosphoinositide 3-kinase by endothelin and ceramide in colonic smooth muscle cells
111. Fas or ceramide induce apoptosis by Ras-regulated phosphoinositide-3-kinase activation
112. Akt regulates cell survival and apoptosis at a postmitochondrial level
113. Sphingolipid metabolism and cell-growth regulation
114. Sphingosine 1-phosphate signalling in mammalian cells
115. Bimodal regulation of ceramidase by interleukin-1 beta: Implications for the regulation of cytochrome p450 2C11
116. Differential regulation of sphingomyelinase and ceramidase activities by growth-factors and cytokines - Implications for cellular proliferation and differentiation
117. Molecular cloning and functional characterization of murine sphingosine kinase
118. Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival
119. Evidence for the presence of multiple forms of Sph kinase in human platelets
120. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate
121. Sphingosine-phosphate lyase
122. Identification of the first mammalian sphingosine phosphate lyase gene and its functional expression in yeast
123. Platelet-derived growth factor-induced activation of sphingosine kinase requires phosphorylation of the PDGF receptor tyrosine residue responsible for binding of PLCgamma
124. Calcium mobilization via sphingosine kinase in sigalling by the Fc epsilon RI antigen receptor
125. FcgammaRI coupling to phospholipase D initiates sphingosine kinase-mediated calcium mobilization and vesicular trafficking
126. Formyl peptide receptor signaling in HL-60 cells through sphingosine kinase
127. An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors
128. Intracellular calcium release mediated by sphingosine derivatives generated in cells
129. Sphingosine 1-phosphate generated in the endoplasmic reticulum membrane activates release of stored calcium
130. Developmental biology: Bringing two hearts together
131. A sphingosine-1-phosphate receptor regulates cell migration during vertebrate heart development
132. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation
133. Structure and function of sphingolipid- and cholesterol-rich membrane rafts
134. The caveolae membrane system
135. Caveolins, a family of scaffolding proteins for organizing 'preassembled signalling complexes' at the plasma membrane
136. The fluid mosaic model of the structure of cell membranes
137. Sphingomyelin: Biophysical aspects
138. Plasma membranes contain half the phospholipid and 90% of the cholesterol and sphingomyelin in cultured human fibroblasts
139. On the origin of sphingolipid/cholesterol-rich detergent-insoluble cell membranes: Physiological concentrations of cholesterol and sphingolipid induce formation of a detergent-insoluble, liquid-ordered lipid phase in model membranes
140. Cholesterol at different bilayer concentrations can promote or antagonize lateral segregation of phospholipids of differing acyl chain length
141. Functions of lipid rafts in biological membranes
142. Sphingolipid organization in biomembranes: What physical studies of model membranes reveal
143. GPI-anchored proteins are organized in submicron domains at the cell surface
144. Intrinsic molecules in lipid membranes change the lipid-domain interracial area: Cholesterol at domain interfaces
145. Agonist-modulated targeting of the EDG-1 receptor to plasmalemmal caveolae: eNOS activation by sphingosine 1-phosphate and the role of caveolin-1 in sphingolipid signal transduction
146. Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling
147. Syn-capping of human T lymphocyte adhesion/activation molecules and their redistribution during interaction with endothelial cells
148. Lymphocyte activation and capping of hormone receptors
149. Co-capping of ras proteins with surface immunoglobulins in B lymphocytes
150. Involvement of cellular caveolae in bacterial entry into mast cells
151. The role of cholesterol and sphigomyelin in tyrosine phosphorylation of proteins and capping of Fcgamma receptor II
152. TNF-alpha-mediated apoptosis is initiated in caveolae-like domains
153. Membrane compartmentation is required for efficient T cell activation
154. Cholesterol and caveolae: Structural and functional relationships
155. Detergent-insoluble glycosphingolipid/cholesterol-rich membrane domains, lipid rafts and caveolae
156. Ultrastructural localization of gangliosides: GM1 is concentrated in caveolae
157. Separation of 'glycosphingolipid signaling domain' from caveolin-containing membrane fraction in mouse melanoma B16 cells and its role in cell adhesion coupled with signaling
158. Evidence that ganglioside enriched domains are distinct from caveolae in MDCK II and human fibroblast cells in culture
159. Caveolar structure and protein sorting are maintained in NIH 3T3 cells independent of glycosphingolipid depletion
160. Use of a photoactivable GM1 ganglioside analogue to assess lipid distribution in caveolae bilayer
161. A photo-reactive derivative of ganglioside GM1 specifically cross-links VIP21-caveolin on the cell surface
162. Ignition of calcium sparks in arterial and cardiac muscle through caveolae
163. Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK)
164. Relaxation of arterial smooth muscle by calcium sparks
165. Vasoregulation by the β1 subunit of the calcium-activated potassium channel
166. Sphingolipid signalling domains floating on rafts or buried in caves?
167. Association of p75(NTR) with caveolin and localization of neurotrophin-induced sphingomyelin hydrolysis to caveolae
168. A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: Potential implications in tumour necrosis factor signalling
169. Caveolin interacts with Trk A and p75(NTR) and regulates neurotrophin signaling pathways
170. Sphingomyelinase induces lipid microdomain formation in a fluid phosphatidylcholine/sphingomyelin membrane